Flash frozen under the electron microscope: Examining the mechanical properties of Alzheimer’s amyloid fibrils

January 26, 2010

(PhysOrg.com) -- Alzheimer’s disease, Parkinson’s disease, type-II diabetes, and prion diseases like BSE all involve the deposition of amyloid fibrils in tissues and organs. These are fibrous clumps of incorrectly folded proteins; their exact structures and their roles in pathological processes are not yet completely understood.

By using electron microscopic images of flash frozen samples, researchers have now been able to examine the exact structure of Alzheimer’s amyloid fibrils and to assess their mechanical properties. As the team reports in the journal , the fibrils are very stiff -- one of the underlying causes of their pathogenicity.

Because amyloid fibrils are very difficult to analyze with traditional biophysical techniques, Marcus Fändrich (Max Planck Unit for Enzymology of Folding, Halle/Saale, Germany), Carsten Sachse (MRC Laboratory of Molecular Biology, Cambridge, UK), and Nikolaus Grigorieff (Brandeis University, Waltham, USA) were forced to take another approach: They examined Alzheimer’s amyloid fibrils by electron cryomicroscopy. “These experiments allowed us to examine the structure of the fibrils at a previously unattainable resolution,” explains Fändrich.

The fibrils appear in twisted bands about 20 nm wide and are often bent in the raw electron microscopic images. “These bent fibrils are a snapshot of the fibrils in solution,” says Fändrich. “We use the degree of bending and twisting to calculate how stiff the fibrils are.” This revealed that the Alzheimer’s amyloid fibrils are relatively rigid structures. “The uncontrolled formation of such stiff fibrils is presumably critical for the pathogenicity of amyloid fibrils,” reports Fändrich. “In many amyloid diseases, the fibrils are preferentially deposited in tissues that are normally contractile or elastic, like the heart muscle or the walls of blood vessels. Medical findings indicate that the fibrils somewhat stiffen these tissues.”

“In addition, our data may help to better evaluate the possible uses of amyloid fibers as novel biotechnological agents,” reports Fändrich. Based on their material properties and ease of modification, amyloid fibers are potentially interesting as novel building materials.

Explore further: Researcher determines link between foie gras and diseases

More information: Marcus Fändrich, Nanoscale Flexibility Parameters of Alzheimer Amyloid Fibrils Determined by Electron Cryo-Microscopy, Angewandte Chemie International Edition 2010, 49, No. 7, Permalink: dx.doi.org/10.1002/anie.200904781

Related Stories

Researcher determines link between foie gras and diseases

June 18, 2007

University of Tennessee Graduate School of Medicine professor and researcher Alan Solomon, M.D., director of the Human Immunology and Cancer/Alzheimer’s Disease and Amyloid-Related Disorders Research Program, led a team ...

Researchers link metal ions to neurodegenerative disease

August 6, 2007

A multi-institutional team of researchers led by Emory University has defined for the first time how metal ions bind to amyloid fibrils in the brain in a way that appears toxic to neurons. Amyloid fibrils are linked to the ...

Destroying amyloid proteins with lasers

January 7, 2009

Researchers have found that a technique used to visualize amyloid fibers in the laboratory might have the potential to destroy them in the clinic. The technique involves zapping the fluorescently-tagged fibers with a laser, ...

Give the foie gras a miss

February 10, 2009

Another reason not to eat pate de foie gras is discussed by Michael Greger of The Humane Society of the United States, Washington DC in a forthcoming issue of the International Journal of Food Safety, Nutrition and Public ...

Study leads to a promising first-in-class drug candidate

July 21, 2009

Discoveries by Scripps Research Institute scientists have led to a promising new drug candidate--the first in its class--for patients with a genetic protein-misfolding disease. In results announced by the biopharmaceutical ...

New therapy targets for amyloid disease

December 4, 2009

A major discovery is challenging accepted thinking about amyloids - the fibrous protein deposits associated with diseases such as Alzheimer's and Parkinson's - and may open up a potential new area for therapeutics.

Recommended for you

Moonlighting molecules: Finding new uses for old enzymes

November 27, 2015

A collaboration between the University of Cambridge and MedImmune, the global biologics research and development arm of AstraZeneca, has led researchers to identify a potentially significant new application for a well-known ...

A new form of real gold, almost as light as air

November 25, 2015

Researchers at ETH Zurich have created a new type of foam made of real gold. It is the lightest form ever produced of the precious metal: a thousand times lighter than its conventional form and yet it is nearly impossible ...

Getting under the skin of a medieval mystery

November 23, 2015

A simple PVC eraser has helped an international team of scientists led by bioarchaeologists at the University of York to resolve the mystery surrounding the tissue-thin parchment used by medieval scribes to produce the first ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.